Patient-reported resilience associated with outcomes after HCT
the ONA take:
Among long-term survivors of hematopoetic celltransplantation (HCT), patient-reported resilience is independently associated with health and psychosocial outcomes, according to a recent study published online ahead of print in Cancer.
Researchers led by Abby Rosenberg, MD, MS, of the Seattle Children’s Hospital observed 4,643 adult survivors of HCT as part of the annual Fred Hutchinson Cancer Research Center (FHCRC) post-transplant survivorship survey from July 2013 to June 2014.
The survey included patient-reported health and functional status as well as instruments that assessed psychosocial outcomes such as the 10-item Connor-Davidson Resilience scale, the Posttraumatic Growth Inventory, and the Cancer and Treatment Distress measure. Among those patients, 1,823 (39%) responded after a single mailing and subsequent reminder letter. Median age was 59 years and 52.5% of patients were male.
The researchers found that lower patient-reported resilience was associated with chronic graft-versus-host disease of higher severity, lower performance scores, missing work for health reasons, and permanent disability.
Upon adjusting for demographic and health characteristics, lower patient-reported resilience scores showed higher odds of having psychological distress as well as being in the lowest quartile for mental health-related quality of life.
“Future studies must determine whether interventions can bolster resilience and improve survivorship outcomes,” the authors concluded.
Among long-term survivors of hematopoetic cell transplantation (HCT), patient-reported resilience is independently associated with outcomes.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|